Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVDTK.L Regulatory News (VDTK)

  • There is currently no data for VDTK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Report for the Six Months to 30 June 2022

7 Sep 2022 15:19

RNS Number : 6630Y
Verditek PLC
07 September 2022
 

Verditek plc

 

("Verditek" or the "Company" or the "Group")

 

Interim Report and Financial Statements for the six months to 30 June 2022

 

Verditek plc, (AIM:VDTK) the clean technology company is pleased to announce its interim results for the six months to 30 June 2022.

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Enquiries:

 

Verditek plc

RH Lord David Willetts FRS (Non-Executive Chairman)

Rob Richards (Chief Executive Officer)

 

Tel: +44 (0)20 7129 7903 enquiries@verditek.com

WH Ireland Limited (NOMAD and Broker)

Chris Hardie (Corporate Finance)

Ben Good (Corporate Finance)

Tel: +44 (0)20 7220 1666

 

 

 

Verditek plc 

("Verditek" or the "Company" or the "Group")

Company Registration No. 10114644

 

Interim Report and Financial Statements

For the six month period to 30 June 2022

 

 

CEO Statement

 

Overview

 

Verditek has seen an encouraging growth in enquiries from potential customers in the six-months to 30 June 2022, and around 50 projects have been delivered in the period, a combination of commercial and trial projects. Verditek has continued to work with strategic partners to develop innovative integrated solar solutions. With recent fuel cost inflation and climate change demands, we see Verditek's offering as well positioned to take advantage of the shift towards clean energy solutions.

 

Strategy

 

The Group's solar strategy continues to be the manufacture and supply of flexible, lightweight solar panels through B2B sales. Verditek remains focussed on working closely with strategic partners to develop and bring to market innovative solutions with integrated solar panels. Our view is that the lightweight roofing market in particular presents significant opportunities for solarisation and we are actively pursuing this market.

 

In light of the current energy crisis and rising cost of fuel we believe that innovative clean energy solutions are becoming an increasingly attractive investment proposition, as Verditek's product offering is well placed to take advantage of the shift away from hydrocarbon-based energy production.

 

Operations

 

Production at the Group's facility in Italy this year has been focused on fulfilment of bespoke orders, rather than producing standard size panels, although we have seen an encouraging increase in sales of standard stock panels.

 

During the period under review, the certification process for Verditek's Generation 1.2 panel (60 cell panel with 340W power output) is still ongoing. This process covers testing to International Standards for temperature, fire, wind, and hail damage as well as durability under normal conditions. Successful certification should allow our panels to be sold in most countries, in the interim period we are focusing on off-grid applications and where certification is not required.

 

The Group is currently developing its Generation 2 panels with enhanced fire-resistance, with a target of producing the world's first lightweight semi-flexible Class-A rated fire-resistant solar panel. This will open up potential markets for solar roof-top applications in the UK, Italy and Australia.

 

Sales and Marketing

The Group has a sales model which uses a network of sales consultants and distributor agents in different regions. To date we are pleased to report that Verditek has delivered projects in 35 countries, which demonstrates the breadth of the network developed over the last 2 years.

 

Verditek continues to advance partnerships with European roofing manufacturers, such as development of an integrated solar roof tile product with Metrotile, a leading provider of lightweight roofing. These solutions can be used on a wide variety of buildings, and significantly expands the potential reach of Verditek's product offering.

 

During the period we were pleased to announce entry into a new segment of the roofing market; a collaboration between our distributor Bradclad Group, a Yorkshire based roof system manufacturer, and Protan AB, the second largest single ply roof membrane ("SPM") manufacturer in Europe, to launch a solution developed for the flat roof market by laminating Verditek solar panels onto SPM. We have successfully delivered the first order for this SPM solution, this first pilot project was relatively small, approximately 35kW, and along with the client and our partners we are now monitoring the outputs, which to date are in line with expected results .

 

Verditek also continues to sell panels direct to businesses; we are delighted to announce that we have recently secured an order to supply 120kW solar panels to an international logistics provider in Thailand who will use the panels on one of their distribution centres. The order uses standard sizes panels from existing inventory, which will be modified according to the specification of the customer. Verditek expects to deliver this project in Q4 2022.

 

Verditek's lightweight panels are ideally suited to this project, where the building structure could not support the use of traditional glass solar panels. Verditek's panels weigh around 2.5kg/m2 and hence were ideal. Furthermore the lease on the building is only for four years and the easy removal, without damage to the building, and relocation to their next building was one of the key criteria in selecting Verditek. This project alone will offset over 190,000 kg of CO2 p.a., with an anticipated payback of less than 5 years for the customer, demonstrating the environmental and commercial advantages of Verditek's product offering.

 

Other Opportunities

 

We are in discussions to license our manufacturing technology to a larger scale, automated plant and we have received expressions of interest from others to build similar plants elsewhere in the world.

 

During the period a third joint development project ("JDP3") commenced with Paragraf, the Cambridge based start-up which has developed world leading graphene technology. JDP3 aims to further explore the performance, scalability and ultimately the commercialisation of graphene photovoltaic ("PV") cells. This technology has the potential to transform the durability and performance of PV cells. We are pleased to report that the project is currently on track and we will be able to review progress later in the year.

 

Work on a project funded by Innovate UK commenced during the period, scheduled to conclude at the end of 2023. The grant is to part fund Verditek to develop, in association with local partners, a robust, ultra-lightweight portable micro solar energy system - providing scalable, renewable power (50W-1.5kW) to off-grid communities in Zimbabwe. The total project cost is just over £450,000 which will be funded to the extent of 70 per cent by Innovate UK. Verditek estimates indicate that 80 per cent of the work will be done by the Company with the local partners performing the remainder. This will enhance the company's presence in emerging markets.

 

Finance

 

For the six-month period to 30 June 2022, the Group generated revenues of £178,502 and recorded a loss after tax of £636,798.

 

On 30 June 2022, the Company announced a capital raise of an additional £1.5m by way of a subscription for ordinary shares. Cash balances as at 30 June 2022 were £1.5m.

 

Overhead spend remains tightly controlled to conserve cash as the conversion time for prospects to become customers has taken longer than expected.

 

Staff

 

With effect from 22 August 2022, John McCall was appointed as Interim CFO due to Vicki Johnson (CFO) going on maternity leave. John is a highly experienced Chartered Accountant with a successful track record in managing high growth businesses. He has been a Group Finance Director for 2 public companies and brings a wealth of experience to Verditek.

 

Outlook and conclusion

 

Despite recent challenges, we continue to see positive opportunities develop for Verditek and believe the significant investment into the development of our flexible, lightweight solar panels will soon bring about meaningful financial reward.

 

I would like to thank all members of the Verditek team, advisers and shareholders for their ongoing support.

 

Rob Richards

Chief Executive Officer

7 September 2022

 

 

Condensed Consolidated Statement of Comprehensive Income

For the six months ended 30 June 2022

 

H1 2022

H1 2021

FY 2021

 

Unaudited

Unaudited

Audited

 

Note

£

£

£

Continuing operations   

 

 

 

Revenue 

3

178,502

105,097

107,632

Direct costs

(256,953)

(565,312)

(609,213)

Gross loss

(78,451)

(460,215)

(501,581)

Administrative expenses 

(666,030)

(678,260)

(1,501,942)

Operating loss   

 

(744,481)

(1,138,475)

(2,003,523)

Other income

4

144,551

-

966,354

Finance Income

 

587

360

335

Finance costs 

(37,455)

(15,985)

(60,553)

Loss before tax   

 

(636,798)

(1,154,100)

(1,097,387)

Income Tax 

-

45

123,308

Loss for the period   

(636,798)

(1,154,055)

(974,079)

 

Loss for the period attributable to: -

 

Owners of the Company

(636,798)

(1,169,834)

(988,479)

Non-controlling interest

 

-

15,779

14,400

(636,798)

(1,154,055)

(974,079)

 

Other comprehensive income

 

Items that will or may be reclassified to profit or loss: 

Translation of foreign operations

23,949

(60,669)

(36,036)

Total comprehensive loss for the period from continuing operations

 

(612,849)

(1,214,724)

(1,010,115)

 

Total comprehensive loss for the period attributable to: -

 

Owners of the Company 

(612,849)

(1,230,503)

(1,024,515)

Non-controlling interest 

-

15,779

14,400

(612,849)

(1,214,724)

(1,010,115)

 

Loss per share

 

Basic and diluted (£)

5

(0.002)

(0.003)

(0.003)

 

Condensed Consolidated Statement of Financial Position

As at 30 June 2022

 

 

As at 30 June 2022

 

As at 30 June 2021

 

 As at 31 December 2021

Note

Unaudited

Unaudited

Audited

 

£

£

£

Assets

 

Non-current assets

 

Investments

-

23,091

990,000

Other receivables

6

773,556

-

-

Property, plant and equipment

274,591

471,892

300,082

Right of use assets

119,320

171,438

142,391

Non-current assets

1,167,467

666,421

1,432,473

 

Current assets

 

Inventories

638,021

555,729

657,151

Trade and other receivables

403,533

296,195

392,193

Cash and cash equivalents 

1,492,380

919,179

237,613

Current assets

2,533,934

1,771,103

1,286,957

TOTAL ASSETS

3,701,401

2,437,524

2,719,430

 

Equity and liabilities

 

Non-current liabilities

 

Loans and borrowings

7

93,304

250,000

277,080

Lease liabilities

64,071

117,941

90,687

Non-current liabilities

157,375

367,941

367,767

 

 

 

 

Current liabilities

Trade and other payables

469,864

471,286

411,213

Loans and borrowings

7

200,252

-

-

Lease liabilities

73,749

64,643

69,737

Current liabilities

 

743,865

535,929

480,950

TOTAL LIABILITIES

901,240

903,870

848,717

Share capital

8

177,415

136,470

136,883

Share premium account

8

12,205,727

10,733,073

10,761,055

Share based payment reserve

270,227

109,079

213,134

Accumulated losses 

(9,735,098)

(9,279,655)

(9,098,300)

Translation reserve 

(11,223)

(59,805)

(35,172)

Non-controlling interests

 

(106,887)

(105,508)

(106,887)

Total shareholders' equity

 

2,800,161

1,533,654

1,870,713

TOTAL EQUITY AND LIABILITIES

 

3,701,401

2,437,524

2,719,430

 

 

Condensed Statement of Changes in Equity

As at 30 June 2022

 

 

 

Issued share capital

Share Premium

Share based payment reserve

Accumulated losses

Translation reserve

Non-controlling interest

Total

 

 £

 £

£

 £

 £

 £

 £

As at 1 January 2021

136,470

10,733,073

99,184

(8,109,821)

864

(121,287)

2,738,483

Loss for the period

-

-

-

(1,169,834)

-

15,779

(1,154,055)

Translation of subsidiary

-

-

-

-

(60,669)

-

(60,669)

Total comprehensive loss for the period

-

-

-

(1,169,834)

(60,669)

15,779

(1,214,724)

Share based payment

-

-

9,895

-

-

-

9,895

Shareholders' equity at 30 June 2021

136,470

10,733,073

109,079

(9,279,655)

(59,805)

(105,508)

1,533,654

Profit/(Loss) for the period

-

-

-

181,355

-

(1,379)

179,976

Translation of subsidiary

-

-

-

-

24,633

-

24,633

Total comprehensive profit/(loss) for the period

-

-

-

181,355

24,634

(1,379)

204,609

Issue of shares net of expenses

413

27,982

-

-

-

-

28,395

Issue of warrants

- corporate bond

-

-

65,903

-

-

-

65,903

Share based payment

-

-

38,152

-

-

-

38,152

Shareholders' equity at 31 December 2021

136,883

10,761,055

213,134

(9,098,300)

(35,172)

(106,887)

1,870,713

Loss for the period

-

-

-

(636,798)

-

-

(636,798)

Translation of subsidiary

-

-

-

-

23,949

-

23,949

Total comprehensive loss for the period

-

-

-

(636,798)

23,949

-

(612,849)

Issue of shares net of expenses

40,532

1,444,672

-

-

-

-

1,485,204

Share based payment

-

-

57,093

-

-

-

57,093

Shareholders' equity at 30 June 2022

177,415

12,205,727

270,227

(9,735,098)

(11,223)

(106,887)

2,800,161

 

 

 

 

Condensed Statement of Cash Flows

For the 6 months ended 30 June 2022

 

 

Note

 

H1 2022

H1 2021

FY 2021

 

Unaudited

Unaudited

Audited

 

£

£

£

Operating activities

 

 

 

 

Loss before tax from continuing operations

(636,798)

(1,154,055)

(1,097,387)

Adjustment for:

Depreciation

59,792

120,115

306,915

Finance costs

37,455

15,985

60,553

Financial income

(587)

(360)

(335)

Fair value changes through P&L - ICSI

4

(26,923)

-

(966,354)

Loss on disposal of assets

501

-

1,582

Share based payment expenses

57,093

9,895

48,047

 

 

(509,467)

(1,008,420)

(1,646,979)

Working capital adjustments

 

 

 

 

(Increase) / decrease in inventory

19,130

80,312

(21,109)

(Increase) / decrease in trade and other receivables

 

(9,098)

129,811

158,455

Increase / (decrease) in trade and other payables

 

(1,019)

(117,124)

(146,699)

Net cash outflow from operating activities

 

(500,455)

(915,421)

(1,656,332)

 

 

Investing activities

 

 

Sale of property, plant and equipment

 

-

-

2,048

Sale of investment

 

307,731

-

-

Purchase of fixed assets

(4,290)

(5,808)

(7,001)

Net cash outflow from investing activities

 

303,441

(5,808)

(4,954)

 

 

Financing activities

 

 

Proceeds from issue of ordinary share capital, net of transaction costs

1,485,205

-

28,395

Loans issued

-

250,000

-

Proceeds from corporate green bonds issued

-

-

353,253

Interest paid on loans

(11,011)

(18,429)

(27,372)

Finance income

 

587

360

334

Repayments of loans

 

-

(70,000)

(98,395)

Payment of lease liabilities

(35,372)

(17,622)

(51,950)

Net cash inflow from financing activities

 

1,439,408

144,309

204,264

 

 

Net (decrease)/increase in cash and cash equivalents

 

1,242,395

(776,920)

(1,457,022)

Cash and cash equivalents at the beginning of the period

237,613

1,711,754

1,711,761

1,480,008

934,834

254,739

Exchange gains on cash and cash equivalents

 

12,372

(15,655)

(17,126)

Cash and cash equivalents at the end of the period

 

1,492,380

919,179

237,613

 

 

Notes to the Condensed Financial Statements

 

1. General Information

 

The Interim Financial Statements are for the six months ended 30 June 2022 and are presented in British Pounds (£), which is the functional currency of the parent company.

 

Verditek plc ("Verditek" or the "Company" or the "Group") is a public limited company incorporated, registered and domiciled in England Wales (registration number 10114644), whose shares are quoted on the Alternative Investment Market on the London Stock Exchange. Its registered office is located at 5 Chancery Lane, London, WC2A 1LG.

 

Verditek is the holding company of a group of companies engaged in the clean technology sector.

 

The Interim Financial Statements have been approved for issue by the Board of Directors on 7 September 2022.

 

2. Basis of Preparation of Half-year Report

 

The financial information presented in this condensed consolidated interim report for the half-year has been prepared in accordance with the recognition and measurement requirements of UK adopted International Accounting Standards ("UK IAS"). The principal accounting policies adopted in the preparation of the financial information in this Interim Report are unchanged from those used in the Company's financial statements for the year ended 31 December 2021.

 

They have been prepared in accordance with IAS 34 'Interim Financial Reporting'. They do not include all of the information required in annual financial statements in accordance with UK IAS and should be read in conjunction with the consolidated financial statements for the year ended 31 December 2021.

 

The financial information for the year ended 31 December 2021 presented in this Interim Report does not constitute the Company's statutory accounts for that period but has been derived from them. The Annual Report and Accounts for the year ended 31 December 2021 were audited and have been filed with the Registrar of Companies. The Independent Auditors' Report on the Annual Report and Accounts for the year ended 31 December 2021 was unqualified and did not contain statements under s498(2) or (3) of the Companies Act 2006, but did contain a material uncertainty in relation to going concern. The financial information for the periods ended 30 June 2021 and 30 June 2022 is unaudited.

 

A copy of the audited consolidated financial statements for the year ended 31 December 2021 is available on the Company's website.

 

New Standards adopted as at 1 January 2022

 

Accounting pronouncements which have become effective from 1 January 2022 are:

 

• Onerous Contracts - Cost of Fulfilling a Contract (Amendments to IAS 37);

• Property, Plant and Equipment: Proceeds before Intended Use (Amendments to IAS 16);

• Annual Improvements to IFRS Standards 2018-2020 (Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41); 

• References to Conceptual Framework (Amendments to IFRS 3).

 

These accounting pronouncements do not have a significant impact on the Group's financial results or position and no changes to existing accounting policies were required as a result of adopting any amendments

 

Going concern

 

The interim financial information has been prepared under the going concern basis as the Directors are satisfied that sufficient funds are or will become available to the Group to meet its on-going working capital requirements for at least the next 12 months. The Group's assessment takes account of current cash resources, expected costs and expected revenues. The Group has a pipeline of commercial opportunities and promising partnerships, and is focussed on converting these into sales in the next year. On 30 June 2022 the Company announced a raise of an additional £1.5m by way of a subscription for ordinary shares.

In the event that trading does not grow as envisaged, sufficient cost reductions are not made, or if there are unforeseen costs, then it is possible that the Company may need to seek additional funding in the next 18 months. Management has successfully raised money in the past, but there is no guarantee that adequate funds will be available when needed in the future. As there can be no guarantee that any required future funding can be raised in the necessary timeframe, a material uncertainty exists that may cast significant doubt on the Company's future ability to continue as a going concern.

 

After considering the forecasts and the risks, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For these reasons, they continue to adopt the going concern basis of accounting.

 

Dividends

 

The Directors do not propose an interim dividend.

 

Material changes in accounting estimates or judgments

 

The preparation of unaudited interim financial information requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses for the current and its corresponding financial period under review. Actual results may differ from these estimates.

 

In preparing the unaudited interim financial information, the significant judgements made by the management in applying the Group's accounting policies and the sources of estimates uncertainty were consistent with those applied to the audited financial statements for the year ended 31 December 2021.

 

3. Segmental Information

 

The chief operating decision-maker is considered to be the Board of Directors of Verditek. The chief operating decision-maker allocates resources and assesses performance of the business and other activities at the operating segment level.

 

The chief operating decision maker has determined that in the period ended 30 June 2022, Verditek had one operating segment, the development and commercialisation of clean technologies. 

 

Revenue and segmental information

 

 

6 months ended 30 June 22

6 months ended 30 June 21

For the year ended 31 December 21

 

Unaudited

Unaudited

Audited

 

£

£

£

Sale of Goods

178,502

105,097

107,632

Total

178,502

105,097

107,632

The Group had two customers that exceeded 10% of revenue in H1 2022.

 

 

Geographical Segments

 

Apart from holding company activities in the UK, the Group had operations in Milan, Italy, in the period. An analysis of revenue, operating loss and non-current assets by geographical market is given below:

 

 

6 months ended 30 June 22

6 months ended 30 June 21

For the year ended 31 December 21

 

Unaudited

Unaudited

Audited

 

£

£

£

Revenue

UK

-

-

-

Rest of Europe

178,502

105,097

107,632

 

178,502

105,097

107,632

Operating loss

 

 

 

UK

(449,376)

(412,202)

(643,547)

Rest of Europe

(295,105)

(726,273)

(1,359,976)

 

(744,481)

(1,138,475)

(2,003,523)

Non-current assets

 

 

 

UK

773,555

23,964

990,599

Rest of Europe

393,912

642,457

441,875

 

1,167,467

666,421

1,432,474

 

4. Other income

6 months ended 30 June 22

6 months ended 30 June 21

For the year ended 31 December 21

 

Unaudited

Unaudited

Audited

£

£

£

 

 

Unwind of discount on ICSI receivable

26,922

-

966,354

 

Grant income

117,629

-

-

 

Total other income

144,551

-

966,354

 

 

Grant income of £117,629 was recognised in association with an Innovate UK grant awarded in 2021, in respect of a project to design solar solutions for homes, schools and farms in Zimbabwe.

During the period there was also an unwind of discount on the receivable recognised upon disposal of the Group's investment Industrial Climate Solutions Inc (ICSI) in February 2022, £26,922.

5. Loss Per Share 

 

The calculation of loss per share is based on the following loss and number of shares:

 

6 months ended 30 June 22

6 months ended 30 June 21

For the year ended 31 December 21

 

Unaudited

Unaudited

Audited

 

 

£

£

£

 

Loss for the period from continuing operations (£)

(636,798)

(1,169,834)

(974,079)

 

Weighted average number of shares: Basic

342,764,826

341,172,443

341,351,150

 

Loss per share (£)

(0.002)

(0.003)

(0.003)

 

 

Basic loss per share is calculated by dividing the loss for the period from continuing operations of the Group by the weighted average number of ordinary shares in issue during the period. Due to the loss in the periods and there are no potentially dilutive ordinary shares, there is no difference between the basic and diluted loss per share.

6. Non-current receivables

 

6 months ended 30 June 22

6 months ended 30 June 21

For the year ended 31 December 21

Unaudited

Unaudited

Audited

£

£

£

 

Earn-out from ICSI investment sale

773,556

-

-

Total non-current receivables

773,556

-

-

 

On 1 February 2022 the Company completed a sale of its stake in the ICSI business. An initial payment of £307,731 was received upon completion. Further payments are expected over a 5 year earn-out period. The payments are linked to achievement of various milestones in development of carbon capture technology, but have been estimated based on management's assessment of the likelihood of success, and discounted to present values. The valuation methodology at 30 June 2022 is consistent with the fair valuation methodology used at 31 December 2021 in measurement of the ICSI investment. During the period there was an unwind of discount of the earn-out receivable of £26,923 (see note 4) and an increase in valuation of £64,332 as a result of foreign exchange movements.

7. Loans and Borrowings

 

6 months ended 30 June 22

6 months ended 30 June 21

For the year ended 31 December 21

Unaudited

Unaudited

Audited

£

£

£

 

Current

Convertible bonds issued to related party

175,252

-

-

Convertible bonds

25,000

-

-

Total current loans and borrowings

200,252

-

-

 

 

 

 

Non-current

 

 

 

Convertible bonds issued to related party

-

25,000

25,000

Convertible bonds

93,304

225,000

252,080

Total Non-current loans and borrowings

93,304

250,000

277,080

 

 

 

 

Total loans and borrowing

293,556

250,000

277,080

 

 

Cashflow - net debt analysis

 

01-Jan-22

Debt Funding

Other cash outflows

Foreign Exchange

Other non-cash movement

30-Jun-22

 

£

£

£

£

£

£

Corporate bonds

252,080

-

-

-

16,476

268,556

Corporate bonds issued to related

party

25,000

-

-

-

-

25,000

Lease liability

160,424

-

(35,372)

3,739

9,029

137,820

437,504

-

(35,372)

3,739

25,505

431,376

 

8. Share capital and reserves

Number

Share capital

Share premium

 

£

£

At 31 December 2020 and 30 June 2021

341,172,443

136,470

10,733,073

Issue of ordinary shares October 2021

1,032,530

413

27,982

At 31 December 2021

342,204,973

136,882

10,761,055

Issue of ordinary shares June 2022

101,333,333

40,533

1,479,467

Share issue costs relating to the share issue

(34,795)

At 30 June 2022

443,538,306

177,415

12,205,727

 

During the period there was an ordinary share issue of 101,333,333 shares at 1.5p per share. There have been no new options granted or exercised in the period and options over 500,000 shares lapsed. The number of shares outstanding on which options have been granted at 30 June 2022 is 19,500,000.

 

9. Events after the reporting date

 

There were no events after the reporting date.

 

10. Copies of the interim report

 

Copies of this interim report will be made available on the Company's website at www.verditek.plc.uk and from the Company's registered office, 5 Chancery Lane, London, WC2A 1LG.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR UBASRUBUKRAR
Date   Source Headline
6th Mar 20244:18 pmRNSHolding(s) in Company
6th Mar 20242:35 pmRNSHolding(s) in Company
6th Mar 20241:22 pmRNSHolding(s) in Company
6th Mar 20241:16 pmRNSHolding(s) in Company
6th Mar 202412:13 pmRNSHolding(s) in Company
6th Mar 20248:55 amRNSChange of Name Effective
5th Mar 20245:07 pmRNSHolding(s) in Company
5th Mar 20244:20 pmRNSHolding(s) in Company
5th Mar 20248:05 amRNSAdmission of Shares, Director Shareholding & TVR
1st Mar 20248:37 amRNSHolding(s) in Company
1st Mar 20247:00 amRNSCompletion, Update and Appointment of Advisers
28th Feb 20243:07 pmRNSResult of General Meeting
28th Feb 20247:00 amRNSProposed Disposal, board changes and fundraising
23rd Feb 202410:31 amRNSReplacement: Update on the Proposed Disposal
23rd Feb 20247:00 amRNSUpdate on the Proposed Disposal
21st Feb 20244:11 pmRNSHolding(s) in Company
15th Feb 202412:43 pmRNSHolding(s) in Company
9th Feb 202410:05 amRNSNotice of General Meeting
7th Feb 20247:00 amRNSProposed Disposal
31st Jan 20244:12 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSHolding(s) in Company
9th Jan 20243:17 pmRNSHolding(s) in Company
8th Jan 20243:50 pmRNSHolding(s) in Company
5th Jan 20243:55 pmRNSHolding(s) in Company
2nd Jan 20243:17 pmRNSResignation of Director
22nd Dec 20237:00 amRNSAdjournment of General Meeting
4th Dec 20237:00 amRNSNotice of General Meeting
29th Nov 20239:02 amRNSFinancing Update
29th Sep 20237:00 amRNSInterim Report for six months to 30 June 2023
8th Sep 20235:15 pmRNSHolding(s) in Company
7th Sep 20234:07 pmRNSHolding(s) in Company
1st Sep 20237:00 amRNSSubscription of Ordinary Shares to raise £500,000
15th Aug 20237:00 amRNSMOU Signed with Net Zero Valley
25th Jul 20233:39 pmRNSResults of 2023 Annual General Meeting
29th Jun 20237:00 amRNSFinal Audited Results
18th May 20237:00 amRNSChange of Registered Office Address
3rd May 20231:12 pmRNSIssue of Secured Convertible Loan Notes 2025
28th Mar 20237:00 amRNSOrder from Roof Tile Group, Belgium
22nd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSSupply Agreement with Lindab Profil AB
20th Feb 20237:00 amRNSVerditek & Bradclad Distribution Agreement Update
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
11th Jan 20232:05 pmRNSSecond Price Monitoring Extn
11th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Oct 20224:07 pmRNSTR1: Notification of Major Holdings
19th Oct 202211:06 amRNSSecond Price Monitoring Extn
19th Oct 202211:00 amRNSPrice Monitoring Extension
19th Oct 20227:00 amRNSVerditek and Bradclad Distribution Agreement
16th Sep 20227:32 amRNSTR1: Notification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.